Aventis's Merilog (insulin-aspart-szjj) as a biosimilar to Novolog (insulin aspart) for adults and pediatric patients with ...

The FDA has approved Merilog, the first-ever rapid-acting insulin biosimilar for diabetes treatment that helps manage blood ...

The FDA has approved Merilog (insulin-aspart-szjj), a biosimilar to Novolog, to improve glycemic control in patients with diabetes mellitus.

Sliding scale insulin therapy involves following a chart of insulin dosages ... 31.4% of 25,813 patients with type 2 diabetes had sliding scale insulin treatment alone. They concluded that ...

Birmingham is suing drug manufacturers and health companies, alleging they worked together to establish an “insulin pricing scheme” and inflate the cost of life-saving medicine. The lawsuit ...

There is also a risk of hypoglycemia or low blood sugar, especially for people taking insulin or medications such as sulfonylureas. This risk is lower with other diabetes medications, but it still ...

The efficacy and safety of and key clinical considerations for using U-500 insulin human ... boxes, and medication bags and the front of the patient's hospital chart at the nursing desk.

"The people who discovered insulin ... Diabetes Association of Minnesota's board of directors, also spoke Monday in the aftermath of the settlement. "Insulin is not an optional medication ...

Metformin is the first-line treatment for the majority of people with type 2 diabetes. Over time, you might need to add other oral meds, insulin, or other injectable drugs, like a GLP-1 receptor ...